Multitargeted sequential therapy with MK-0457 and dasatinib followed by stem cell transplantation for T315I mutated chronic myeloid leukemia

Leuk Res. 2009 Jun;33(6):e20-2. doi: 10.1016/j.leukres.2008.10.020. Epub 2008 Nov 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Dasatinib
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Mutation*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Thiazoles / therapeutic use*

Substances

  • Antineoplastic Agents
  • Piperazines
  • Pyrimidines
  • Thiazoles
  • tozasertib
  • Dasatinib